Search results
Justin Bieber Gets His Smile Back Nine Months After Facial Paralysis Diagnosis
Rolling Stone via Yahoo News· 1 year agoJustin Bieber’s face was left partially paralyzed in June 2022 after he was diagnosed with Ramsey...
How Social Support — Both Online and IRL — Helps Those with Endometriosis Advocate for Their Health
Shape via Yahoo News· 1 year agoWomen, including celebrities such as Olivia Culpo, are speaking up about the importance of sharing...
Like Sinéad O’Connor, my mother died of broken heart syndrome after losing her son
The Telegraph via Yahoo News· 4 months agoWhen I read that Sinéad O’Connor had died of what her former partner, Dermot Hayes, called a “broken...
Bristol Myers (BMY) Wins EC Nod for Reblozyl Label Expansion
Zacks via Yahoo Finance· 4 weeks agoBristol Myers Squibb BMY announced that the European Commission (EC) has approved a label expansion...
Long COVID damage can linger for 2 years, leading to elevated risk of disability, hospitalization,...
Fortune via Yahoo Finance· 8 months agoLong COVID—and the increased risk of death, disability, and hospitalization it brings—can persist...
Boston Scientific's (BSX) Wavewriter Alpha SCS Gets FDA's Nod
Zacks via Yahoo Finance· 6 months agoBoston Scientific, Inc. BSX recently received FDA approval for an expanded indication of the...
Biotech Stock Roundup: REGN Up on Approval, APLS, NVAX Gain on Updates & More
Zacks via Yahoo Finance· 8 months agoIt was a busy week for the biotech sector, with quite a few important updates. Among these,...
Novartis' (NVS) Sandoz Gets FDA Nod for Tysabri's Biosimilar
Zacks via Yahoo Finance· 8 months agoNovartis’ NVS generic arm, Sandoz, announced that the FDA approved Tyruko (natalizumab-sztn), a...
bluebird's (BLUE) Gene Therapy Gets FDA Nod for CALD
Zacks via Yahoo Finance· 2 years agobluebird bio BLUE recently received accelerated FDA approval for Syskona (elivaldogene autotemcel), also known as eli-cel, as a treatment for patients...
AbbVie (ABBV) Vraylar Gets FDA Nod for Major Depressive Disorder
Zacks via Yahoo Finance· 1 year agoAbbVie ABBV announced that the FDA has approved Vraylar (cariprazine) for the adjunctive treatment...